TL;DR
CellCanon is the first "agentic" cellular world model that unifies single-cell perturbation prediction, evidence-grounded explanation, and real-time updating from new experimental observations. By integrating molecular knowledge into a shared world state, it achieves a massive 63% improvement in differential expression prediction while reducing computational costs (LLM tokens) by over 99% compared to gene-wise reasoning approaches.
What Problem Does This Paper Address?
Understanding how cells respond to drugs is central to biological discovery, but the combinatorial space of drugs, doses, and cell types is too vast to measure experimentally. While numerical models can predict these responses, they are often "black boxes" that can't explain why a prediction was made. Conversely, Large Language Models (LLMs) can reason about biology but are computationally expensive when applied to thousands of genes individually.
Furthermore, most models are static; they cannot easily incorporate new experimental data to refine their predictions for unobserved conditions without expensive retraining. CellCanon addresses this by creating a unified agent that can predict, explain its reasoning using established biological literature, and update its internal "world state" as new data arrives.
Methods
CellCanon introduces an agentic architecture centered around a Shared World State. This state links numerical predictions, acquired measurements, and source-linked biological claims.
- Knowledge-Conditioned Retrieval: Instead of reasoning gene-by-gene, CellCanon uses an LLM (like DeepSeek-V4-Flash) to compile a "condition-level" evidence packet. This includes drug-target interactions, pathways, and baseline cell expression from databases like ChEMBL and Reactome.
- Predictive Core: This evidence is encoded into a shared representation that guides gene-specific numerical readouts (MLPs). These readouts predict continuous response, differential expression (DE) probability, and direction (up/down).
- Mechanism Explainer: The agent evaluates regulatory paths to provide proofs for its claims or identify cases where evidence is insufficient.
- Observation-Driven Update: When a new measurement is provided (e.g., a drug's effect on a new cell line), the agent uses a kernel-based updater to revise predictions for that same drug in other, still-unmeasured contexts—all without changing the underlying model weights.
Datasets
- SciPlex3: The primary evaluation dataset, containing transcriptional responses for thousands of drugs across three cell lines (A549, K562, MCF7).
- Knowledge Bases: Integrated data from ChEMBL, Reactome, OmniPath, DoRothEA, PROGENy, and MSigDB.
- Source-Grounded Benchmark: A newly introduced benchmark of 966 questions across 72 conditions designed to test the model's ability to provide evidence-linked explanations.
Key Insights and Ideas
- Context Sharing is Key: The authors realized that genes in a single drug-cell condition share the same biological background. By compiling this evidence once per condition rather than once per gene, they achieved a 99.77% reduction in token usage for predictions.
- Hybrid Numerical-Symbolic Reasoning: CellCanon bridges the gap between "sub-symbolic" neural networks (which handle messy expression data) and "symbolic" biological knowledge (which handles discrete facts like "Drug A inhibits Protein B").
- In-Context Biological Learning: The "Update" feature acts as a form of in-context learning for biology. By seeing how a drug behaves in one cell type, the model can immediately improve its "belief" about how that drug will behave in another, similar cell type.
Key Results
- State-of-the-Art Prediction: On 339 held-out conditions, CellCanon improved differential-expression AUPRC by 63.3% and Macro-F1 by 17.3% over the best existing baselines.
- Superior Correlation: It reached a logFC Pearson correlation of 0.6944, significantly higher than the 0.4306 achieved by chemCPA.
- Perfect Grounding: In the explanation benchmark, the model correctly answered all answerable questions with supporting proofs and correctly identified every case where evidence was insufficient.
- Efficient Updating: In simulated feedback loops, using just one measured context per drug allowed CellCanon to exceed the performance of baselines that were fully fine-tuned on the new data.
Limitations and Future Work
- Knowledge Base Dependency: The model's explanatory power is limited by the completeness of the underlying knowledge bases (e.g., if a drug-target interaction isn't in ChEMBL, the model may struggle).
- Scope of Perturbations: The current study focuses on chemical perturbations; extending this to genetic perturbations (like CRISPR screens) or multi-drug combinations is a logical next step.
- Real-time Interaction: While agentic, the current implementation is evaluated in a simulated feedback loop. Deploying this in an active lab environment to guide real-time experimental design remains future work.
Summary updated